This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Cytosite Biopharma Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Julia Marie Clay: Innovator in Granzyme B Imaging and Therapy
Introduction
Julia Marie Clay is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biomedical research, particularly in the area of immunotherapy. Her innovative work focuses on developing compounds that can effectively target granzyme B, a key player in immune responses.
Latest Patents
Julia holds a patent for her invention titled "Granzyme B directed imaging and therapy - Compounds of Formula (I) and Formula (II)." This patent describes compounds capable of binding to granzyme B, which are essential for imaging and treating immunoregulatory abnormalities. Her work in this area has the potential to advance therapeutic strategies for various diseases.
Career Highlights
Throughout her career, Julia has been associated with Cytosite Biopharma Inc., where she has been instrumental in driving research and development efforts. Her expertise in immunology and therapeutic applications has positioned her as a valuable asset in the field.
Collaborations
Julia has collaborated with notable colleagues, including Hui Xiong and Kevin Michael Ruley. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Julia Marie Clay's contributions to granzyme B imaging and therapy exemplify her dedication to advancing medical science. Her innovative spirit and collaborative efforts continue to inspire progress in the field of immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile